ORIC
ORIC Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +11.1% ·
Aktienfluss +26.5% ·
neue Nettopositionen +10.0%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | 0 | 59.02M | $639.12M | +7 | −7 |
| Q1 2026 | 75 | +3 | 50.35M | $637.44M | +9 | −6 |
| Q4 2025 | 72 | +1 | 55.15M | $451.14M | +1 | — |
| Q3 2025 | 17 | 0 | 34.78M | $417.41M | — | — |
| Q2 2025 | 14 | +1 | 27.12M | $275.30M | +3 | −2 |
| Q1 2025 | 10 | +1 | 12.33M | $68.78M | +2 | −1 |
| Q4 2024 | 9 | -1 | 9.74M | $78.61M | — | −1 |
| Q3 2024 | 9 | 0 | 7.63M | $78.26M | +1 | −1 |
| Q2 2024 | 9 | — | 8.42M | $59.53M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 6.57M | +48.3% | $36.68M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passiv) | 2.20M | +19.0% | $12.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.33M | +2.9% | $7.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.33M | +2.9% | $7.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 1.31M | +2.1% | $7.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passiv) | 1.31M | +2.1% | $7.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 511.89K | +1305.3% | $2.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 178.22K | -4.4% | $994,451 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 178.22K | -4.4% | $994,451 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 76.99K | -44.9% | $429,604 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 53.98K | +95.3% | $301,225 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 49.53K | Neu | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 49.53K | Neu | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 49.53K | Neu | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 49.53K | Neu | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 49.53K | Neu | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 47.70K | Neu | $266,138 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| Marshall Wace | $266,138 | 0.0% |
Ausgestiegen
| Adage Capital Partners | $4.04M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 181 Inhaber, 119.04M Anteile, $1.43B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.